|
|
Article: WATSON PHARMACEUTICALS ANNOUNCES JOINT VENTURE IN CHINA
- Article from:
- PR Newswire
- Article date:
- March 6, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CORONA, Calif., March 6 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (Nasdaq: WATS) today announced that its wholly-owned subsidiary, Watson Pharmaceuticals (Asia) Ltd. ("Watson (Asia)"), has agreed to form two joint ventures with China-based Changzhou No. 4 Pharmaceutical Factory ("Changzhou"). The first joint venture, Changzhou Watson Pharmaceutical Co. Ltd. ("Joint Venture A") will establish a manufacturing facility in China for the production of pharmaceuticals and related products. Joint Venture A will market and sell products in China, with products outside China being sold through Watson (Asia).
A second joint venture between Watson (Asia) and Changzhou will ...
Related newspaper, magazine, and journal articles:
|
|
Article: Watson Pharmaceuticals Reports Record Fourth ...
PR Newswire;
February 6, 1997 ;
700+ words
... ... PRNewswire/ -- Watson Pharmaceuticals, Inc. (Nasdaq ... s 50 percent joint venture, Somerset Pharmaceuticals ... Commission filings. Watson Pharmaceuticals, Inc., headquartered ... pharmaceutical products. Watson Pharmaceuticals, Inc. Consolidated ...
|
|